Catalyst Wire Dossier Catalyst Wire Dossier

ARD103 CAR-T cell therapy

· ARCE Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARD103 CAR-T cell therapy, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

See pricing